186 related articles for article (PubMed ID: 33171060)
1. SEC61G plays an oncogenic role in hepatocellular carcinoma cells.
Gao H; Niu W; He Z; Gao C; Peng C; Niu J
Cell Cycle; 2020 Dec; 19(23):3348-3361. PubMed ID: 33171060
[TBL] [Abstract][Full Text] [Related]
2. SEC61G is upregulated and required for tumor progression in human kidney cancer.
Meng H; Jiang X; Wang J; Sang Z; Guo L; Yin G; Wang Y
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33846795
[TBL] [Abstract][Full Text] [Related]
3. miR-10b exerts oncogenic activity in human hepatocellular carcinoma cells by targeting expression of CUB and sushi multiple domains 1 (CSMD1).
Zhu Q; Gong L; Wang J; Tu Q; Yao L; Zhang JR; Han XJ; Zhu SJ; Wang SM; Li YH; Zhang W
BMC Cancer; 2016 Oct; 16(1):806. PubMed ID: 27756250
[TBL] [Abstract][Full Text] [Related]
4. SEC61G identified as a prognostic biomarker of head and neck squamous cell carcinoma.
Shi Y; Liang Y; Wang W; Zhang G
Eur Arch Otorhinolaryngol; 2022 Apr; 279(4):2039-2048. PubMed ID: 34173014
[TBL] [Abstract][Full Text] [Related]
5. MTP18 overexpression contributes to tumor growth and metastasis and associates with poor survival in hepatocellular carcinoma.
Zhang Y; Li H; Chang H; Du L; Hai J; Geng X; Yan X
Cell Death Dis; 2018 Sep; 9(10):956. PubMed ID: 30237394
[TBL] [Abstract][Full Text] [Related]
6. SEC61G overexpression and DNA amplification correlates with prognosis and immune cell infiltration in head and neck squamous cell carcinoma.
Lu T; Chen Y; Gong X; Guo Q; Lin C; Luo Q; Tu Z; Pan J; Li J
Cancer Med; 2021 Nov; 10(21):7847-7862. PubMed ID: 34590792
[TBL] [Abstract][Full Text] [Related]
7. The long noncoding RNA
Qi H; Lu Y; Lv J; Wu H; Lu J; Zhang C; Zhang S; Bao Q; Zhang X; Xie C; Yin Z
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29776974
[TBL] [Abstract][Full Text] [Related]
8. Metabolic pathway analyses identify proline biosynthesis pathway as a promoter of liver tumorigenesis.
Ding Z; Ericksen RE; Escande-Beillard N; Lee QY; Loh A; Denil S; Steckel M; Haegebarth A; Wai Ho TS; Chow P; Toh HC; Reversade B; Gruenewald S; Han W
J Hepatol; 2020 Apr; 72(4):725-735. PubMed ID: 31726117
[TBL] [Abstract][Full Text] [Related]
9. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
[TBL] [Abstract][Full Text] [Related]
10. Suppression of KIF3B expression inhibits human hepatocellular carcinoma proliferation.
Huang X; Liu F; Zhu C; Cai J; Wang H; Wang X; He S; Liu C; Yao L; Ding Z; Zhang Y; Zhang T
Dig Dis Sci; 2014 Apr; 59(4):795-806. PubMed ID: 24368420
[TBL] [Abstract][Full Text] [Related]
11. BUB1B promotes hepatocellular carcinoma progression via activation of the mTORC1 signaling pathway.
Qiu J; Zhang S; Wang P; Wang H; Sha B; Peng H; Ju Z; Rao J; Lu L
Cancer Med; 2020 Nov; 9(21):8159-8172. PubMed ID: 32977361
[TBL] [Abstract][Full Text] [Related]
12. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
13. Circular RNA circ-FOXP1 induced by SOX9 promotes hepatocellular carcinoma progression via sponging miR-875-3p and miR-421.
Wang W; Li Y; Li X; Liu B; Han S; Li X; Zhang B; Li J; Sun S
Biomed Pharmacother; 2020 Jan; 121():109517. PubMed ID: 31698267
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-183-5p contributes to malignant progression through targeting PDCD4 in human hepatocellular carcinoma.
Duan X; Li W; Hu P; Jiang B; Yang J; Zhou L; Mao X; Tian B
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33078826
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.
Zhao G; Wang T; Huang QK; Pu M; Sun W; Zhang ZC; Ling R; Tao KS
World J Gastroenterol; 2016 Jun; 22(23):5364-73. PubMed ID: 27340352
[TBL] [Abstract][Full Text] [Related]
16. Potential dual functional roles of the Y-linked RBMY in hepatocarcinogenesis.
Kido T; Tabatabai ZL; Chen X; Lau YC
Cancer Sci; 2020 Aug; 111(8):2987-2999. PubMed ID: 32473614
[TBL] [Abstract][Full Text] [Related]
17. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.
Zheng Y; Jiang L; Hu Y; Xiao C; Xu N; Zhou J; Zhou X
BMC Cancer; 2017 Feb; 17(1):161. PubMed ID: 28241806
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-216b suppresses the cell growth of hepatocellular carcinoma by inhibiting Ubiquitin-specific peptidase 28 expression.
Zhang JF
Kaohsiung J Med Sci; 2020 Jun; 36(6):423-428. PubMed ID: 32053284
[TBL] [Abstract][Full Text] [Related]
19. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-493 suppresses hepatocellular carcinoma tumorigenesis through down-regulation of anthrax toxin receptor 1 (ANTXR1) and R-Spondin 2 (RSPO2).
Xu Y; Ge K; Lu J; Huang J; Wei W; Huang Q
Biomed Pharmacother; 2017 Sep; 93():334-343. PubMed ID: 28651234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
